GDF10 and breast carcinoma: Using multiomic integration of genomic and transcriptomic data, Rahman and coworkers (Rahman et al., 2020) found evidence of GDF10 as a novel therapeutic biomarker for breast cancer, finding that downregulation of GDF10 is associated with breast cancer progression and patient’s survival, thus becoming a therapeutic biomarker for treating breast tumors.